doksorubitsiin
Doksorubitsiin, known in English as doxorubicin, is an anthracycline antibiotic used in cancer chemotherapy. It is a cytotoxic agent derived from the soil bacterium Streptomyces peucetius. Its mechanism involves intercalation into DNA, inhibition of the enzyme topoisomerase II, and generation of reactive oxygen species, leading to DNA damage and apoptosis in rapidly dividing cancer cells.
Doksorubitsiin is used to treat a range of solid tumors and blood cancers, including breast cancer, non-Hodgkin
Administration and pharmacokinetics: Doksorubitsiin is administered intravenously, with careful monitoring for infusion reactions and the risk
Side effects and safety: Common adverse effects include bone marrow suppression, nausea, vomiting, mucositis, alopecia, and